Researchers@EVMS
Toggle navigation
Browse
Home
People
Departments
Research Areas
Capability Map
Publications
Events
Clinical Trials
Student Opportunities
FAQ
IMMUNOTHERAPY
Journal
Overview
Identity
View All
Overview
publication venue for
Dupilumab in the treatment of chronic rhinosinusitis with nasal polyposis
. 12:111-121.
2020
A review of phase III clinical trials of US FDA-approved biologic therapies for chronic rhinosinusitis with nasal polyposis
2022
Identity
International Standard Serial Number (ISSN)
1750-743X
Electronic International Standard Serial Number (EISSN)
1750-7448
